Coadministration of lopinavir/ritonavir and phenytoin results in two-way drug interaction through cytochrome P-450 induction
Article Abstract:
The effects of phenytoin (PHT) coadministration on the pharmacokinetics (PK) of lopinavir/ritonavir and also the effects of lopinavir/ritonavir on the PK of PHT, through cytochrome P-450 induction, are determined. Management should be individualized to each patient as the changes in dosage or alterations of antiretroviral or anticonvulsant regimens is necessary.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Deep salvage with amprenavir and lopinavir/ritonavir: correlation of pharmacokinetics and drug resistance with pharmacodynamics
Article Abstract:
Deep salvage therapy using lopinavir/ritonavir with amprenavir is safe and shows partial virologic inhibition and good immunologic efficacy. Pharmacokinetics enhancement of amprenavir with ritonavir shows increase drug levels above the susceptibility threshold of several resistant viral strains as well as allows a reduction of the pill burden.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
Association of HIV-1 replication capacity with treatment outcomes in patients with virologic treatment failure
Article Abstract:
The correlation between viral replication capacity (RC) and treatment outcomes is analyzed by studying for up to three years, patients failing antiretroviral therapy enrolled in the Antiretroviral Genotypic Resistance and Patient-reported Adherence (ARGENTA) trial.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Increased dose of lopinavir/ritonavir compensates for efavirenz-induced drug-drug interaction in HIV-1-infected children
- Abstracts: Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America. Durable efficacy of enfuvirtide over 48 weeks in heavily treatment-experienced HIV-1-infected patients in the T-20 versus optimized background regimen into 1 and 2 clinical trials
- Abstracts: Folic acid fortification of the food supply: potential benefits and risks for the elderly population
- Abstracts: Associations of sexual risk taking among Kenyan female sex workers after enrollment in an HIV-1 prevention trial
- Abstracts: Modeling long-term HIV dynamics and antiretroviral response: Effects of drug potency, pharmacokinetics, adherence, and drug resistance